LBF20207PG46: Difference between revisions
No edit summary |
No edit summary |
||
(14 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
Line 4: | Line 6: | ||
|LipidBank=XPR1788 | |LipidBank=XPR1788 | ||
|LipidMaps=- | |LipidMaps=- | ||
|SysName= | |SysName=(9alpha,11alpha,15S) -Trihydroxy- (8beta) -prosta- (cis-5,trans-13) -dien-1-oic acid | ||
|Common Name=&&8-iso Prostaglandin | |Common Name=&&8-iso Prostaglandin F_2 alpha&&(9alpha,11alpha,15S) -Trihydroxy- (8beta) -prosta- (5Z,13E) -dien-1-oic acid&& | ||
|Source=In normal human urine, 8-iso PGF2 alpha level are about 180-200 pg/mg of creatinine.[[Reference:Morrow_JD:Hrris_TM:Roberts_LJ:2nd:,Anal. Biochem.,1990,184,1|{{RelationTable/GetFirstAuthor|Reference:Morrow_JD:Hrris_TM:Roberts_LJ:2nd:,Anal. Biochem.,1990,184,1}}]] | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=8-iso PGF2 alpha is reported to inhibit platelet aggregation induced by U-46619 (1 mu M) and I-BOP (0.3 mu M) with IC50 of 1.6 mu M and 1.8 mu M, respectively.[[Reference:Morrow_JD:Minton_TA:Roberts_LJ:2nd:,Prostaglandins,1992,44,155|{{RelationTable/GetFirstAuthor|Reference:Morrow_JD:Minton_TA:Roberts_LJ:2nd:,Prostaglandins,1992,44,155}}]] | |||
}} | }} | ||
{{Lipid/Footer}} |
Latest revision as of 08:36, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1788 |
LipidMaps | - |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG46 |
8-iso Prostaglandin F2α | |
---|---|
Structural Information | |
(9α,11α,15S) -Trihydroxy- (8β) -prosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CC[C@H](O)C=C[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
In normal human urine, 8-iso PGF2 alpha level are about 180-200 pg/mg of creatinine. Morrow_JD et al. | |
8-iso PGF2 alpha is reported to inhibit platelet aggregation induced by U-46619 (1 mu M) and I-BOP (0.3 mu M) with IC50 of 1.6 mu M and 1.8 mu M, respectively. Morrow_JD et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|